000 01284 a2200373 4500
005 20250512083040.0
264 0 _c19850627
008 198506s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/BF00258131
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlison, D L
245 0 0 _aThe clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717).
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1985
300 _a265-71 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xmetabolism
650 0 4 _aFolic Acid
_xanalogs & derivatives
650 0 4 _aFolic Acid Antagonists
_xmetabolism
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aLiver
_xdrug effects
650 0 4 _aProtein Binding
650 0 4 _aQuinazolines
_xmetabolism
650 0 4 _aTissue Distribution
700 1 _aNewell, D R
700 1 _aSessa, C
700 1 _aHarland, S J
700 1 _aHart, L I
700 1 _aHarrap, K R
700 1 _aCalvert, A H
773 0 _tCancer chemotherapy and pharmacology
_gvol. 14
_gno. 3
_gp. 265-71
856 4 0 _uhttps://doi.org/10.1007/BF00258131
_zAvailable from publisher's website
999 _c4001371
_d4001371